{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:00:01Z","timestamp":1785376801117,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.atherosclerosis.2014.12.044","type":"journal-article","created":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T04:45:37Z","timestamp":1419309937000},"page":"101-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["The association of resistin with cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis"],"prefix":"10.1016","volume":"239","author":[{"given":"Evan D.","family":"Muse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Blaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6026-3329","authenticated-orcid":false,"given":"Zeina A.","family":"Dardari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9616-1946","authenticated-orcid":false,"given":"Matthew J.","family":"Budoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurram","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Criqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn L.","family":"McClelland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.12.044_bib1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJMra1201534","article-title":"Measuring the global burden of disease","volume":"369","author":"Murray","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.044_bib2","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/01.cir.0000441139.02102.80","article-title":"Heart disease and stroke statistics\u20132014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2013","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2014.12.044_bib3","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","article-title":"Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss","volume":"53","author":"Lavie","year":"2009","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.044_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1540\/jsmr.48.27","article-title":"Human resistin in cardiovascular disease","volume":"48","author":"Lee","year":"2012","journal-title":"J.\u00a0Smooth Muscle Res."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2014.12.044_bib5","first-page":"259","article-title":"Human resistin: found in translation from mouse to man","volume":"22","author":"Schwartz","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2014.12.044_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.tcm.2007.09.005","article-title":"The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives","volume":"17","author":"Gualillo","year":"2007","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.atherosclerosis.2014.12.044_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.044_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2796.2004.01306.x","article-title":"The current biology of resistin","volume":"255","author":"Steppan","year":"2004","journal-title":"J.\u00a0Intern. Med."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.044_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1172\/JCI200421270","article-title":"Role of resistin in diet-induced hepatic insulin resistance","volume":"114","author":"Muse","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2014.12.044_bib10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbrc.2003.07.003","article-title":"Resistin messenger-RNA expression is increased by proinflammatory cytokines in\u00a0vitro","volume":"309","author":"Kaser","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2014.12.044_bib11","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.CIR.0000155620.10387.43","article-title":"Resistin is an inflammatory marker of atherosclerosis in humans","volume":"111","author":"Reilly","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.12.044_bib12","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.2337\/diacare.27.10.2450","article-title":"Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes","author":"Shetty","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2014.12.044_bib13","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.4049\/jimmunol.174.9.5789","article-title":"Resistin, an adipokine with potent proinflammatory properties","volume":"174","author":"Bokarewa","year":"2005","journal-title":"J.\u00a0Immunol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.044_bib14","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1371\/journal.pmed.0010045","article-title":"An inflammatory cascade leading to hyperresistinemia in humans","volume":"1","author":"Lehrke","year":"2004","journal-title":"PLoS Med."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.12.044_bib15","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2265.2008.03375.x","article-title":"Resistin gene variation is associated with systemic inflammation but not plasma adipokine levels, metabolic syndrome or coronary atherosclerosis in nondiabetic Caucasians","volume":"70","author":"Qasim","year":"2009","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.044_bib16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.metabol.2007.11.010","article-title":"Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults","volume":"57","author":"Aquilante","year":"2008","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.044_bib17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.atherosclerosis.2012.12.029","article-title":"Adipokines as mediators of endothelial function and atherosclerosis","volume":"227","author":"Ntaios","year":"2013","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.044_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.atherosclerosis.2005.02.014","article-title":"The potential role of resistin in atherogenesis","volume":"182","author":"Burnett","year":"2005","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.044_bib19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.yjmcc.2008.05.006","article-title":"Role of resistin in cardiac contractility and hypertrophy","volume":"45","author":"Kim","year":"2008","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"issue":"19","key":"10.1016\/j.atherosclerosis.2014.12.044_bib20","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.jacc.2011.11.064","article-title":"Discovery of a new role of human resistin in hepatocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subtilisin\/kexin type 9","volume":"59","author":"Melone","year":"2012","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2014.12.044_bib21","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jacc.2008.07.073","article-title":"Resistin, adiponectin, and risk of heart failure the Framingham offspring study","volume":"53","author":"Frankel","year":"2009","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.044_bib22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.atherosclerosis.2006.11.017","article-title":"Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean atherosclerosis study (KAS): a 42-month prospective study","volume":"196","author":"Lim","year":"2008","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.044_bib23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ijo.2009.204","article-title":"Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study","volume":"34","author":"Luc","year":"2010","journal-title":"Int. J. Obes. (Lond)"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.12.044_bib24","doi-asserted-by":"crossref","first-page":"e64729","DOI":"10.1371\/journal.pone.0064729","article-title":"Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes","volume":"8","author":"Menzaghi","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2014.12.044_bib25","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1253\/circj.CJ-11-1549","article-title":"Prognostic value of circulating adipokine levels and expressions of adipokines in the myocardium of patients with chronic heart failure","volume":"76","author":"Yin","year":"2012","journal-title":"Circ. J."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2014.12.044_bib26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/aje\/kwf113","article-title":"Multi-ethnic study of atherosclerosis: objectives and design","volume":"156","author":"Bild","year":"2002","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.044_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ahj.2011.09.029","article-title":"Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham offspring study","volume":"163","author":"Rienstra","year":"2012","journal-title":"Am. Heart J."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2014.12.044_bib28","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/ATVBAHA.109.186783","article-title":"Serum resistin concentrations and risk of new onset heart failure in older persons: the health, aging, and body composition (Health ABC) study","volume":"29","author":"Butler","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2014.12.044_bib29","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.cardfail.2011.08.010","article-title":"Dynamics in insulin resistance and plasma levels of adipokines in patients with acute decompensated and chronic stable heart failure","volume":"17","author":"Schulze","year":"2011","journal-title":"J.\u00a0Card. Fail."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.044_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cardfail.2010.08.007","article-title":"Association of resistin with heart failure and mortality in patients with stable coronary heart disease: data from the heart and soul study","volume":"17","author":"Zhang","year":"2011","journal-title":"J.\u00a0Card. Fail."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.12.044_bib31","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/eurjhf\/hfs111","article-title":"High leptin and resistin expression in chronic heart failure: adverse outcome in patients with dilated and inflammatory cardiomyopathy","volume":"14","author":"Bobbert","year":"2012","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.044_bib32","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/CIRCHEARTFAILURE.111.964031","article-title":"Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation","volume":"5","author":"Khan","year":"2012","journal-title":"Circ. Heart Fail."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.12.044_bib33","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.amjcard.2013.04.053","article-title":"Relation of leptin to left ventricular hypertrophy (from the Multi-Ethnic Study of Atherosclerosis)","volume":"112","author":"Allison","year":"2013","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2014.12.044_bib34","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/oby.2011.32","article-title":"Relations of circulating resistin and adiponectin and cardiac structure and function: the Framingham offspring study","volume":"20","author":"McManus","year":"2012","journal-title":"Obes. (Silver Spring)"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.044_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clim.2009.07.013","article-title":"The role of resistin as a regulator of inflammation: implications for various human pathologies","volume":"133","author":"Filkov\u00e1","year":"2009","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.044_bib36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jjcc.2013.10.008","article-title":"Increased level of resistin predicts development of atrial fibrillation","volume":"63","author":"\u00d6zcan","year":"2014","journal-title":"J.\u00a0Cardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.044_bib37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000348651","article-title":"Correlation between levels of circulating adipokines and adiponectin\/resistin index with carotid intima-media thickness in hypertensive type 2 diabetic patients","volume":"125","author":"Rubio-Guerra","year":"2013","journal-title":"Cardiology"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.044_bib38","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/ATVBAHA.110.220673","article-title":"Association of adiponectin, resistin, and vascular inflammation: analysis with 18F-fluorodeoxyglucose positron emission tomography","volume":"31","author":"Choi","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014016669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014016669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T15:52:47Z","timestamp":1537977167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014016669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0021915014016669"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.044","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of resistin with cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}